Results 61 to 70 of about 1,235,496 (168)

Chronic kidney disease

The Lancet
Globally, the prevalence of chronic kidney disease is estimated to be approximately 850 million cases, with approximately 4 million individuals needing kidney replacement therapy for kidney failure. By 2050, chronic kidney disease is projected to become the fifth leading underlying cause of death worldwide.
Herrington, WG, Judge, PK, Grams, ME, Wanner, C   +3 more
openaire   +2 more sources

High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study

Nutrition & Metabolism, 2019
Background The results remain controversial with regards to the impact of serum uric acid on clinical outcomes from peritoneal dialysis population. The aim of our study was to investigate the influence of serum uric acid levels on mortality in peritoneal
Shilong Xiang, Xiaohui Zhang, Xishao Xie, Junni Wang, Qin Zhou, Zhimin Chen, Yaomin Wang, Guangjun Liu, Fei Han, Jianghua Chen   +9 more
doaj   +1 more source

Diseases of the Kidneys [PDF]

Annual Review of Medicine, 1950
openaire   +2 more sources

Kidney age, not kidney disease [PDF]

Canadian Medical Association Journal, 2019
Stevens, R, Evans, J, Oke, J
openaire   +2 more sources

Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids

Stem Cell Research & Therapy
Background Induced pluripotent stem cells (iPSCs)-derived kidney organoids are a promising model for studying disease mechanisms and renal development. Despite several protocols having been developed, further improvements are needed to overcome existing ...
Ekaterina Pecksen, Sergey Tkachuk, Cristoph Schröder, Marc Vives Enrich, Anindita Neog, Cory P. Johnson, Niko Lachmann, Hermann Haller, Yulia Kiyan   +8 more
doaj   +1 more source

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis

BMC Nephrology
Background To compare the efficacy and safety of rituximab (RTX), calcineurin inhibitor (CNI) and cyclophosphamide (CTX) plus glucocorticoids in the treatment of primary membranous nephropathy (PMN).
Luying Lu, Shasha Cai, Huayan Zhu, Guangjun Liu, Yaomin Wang, Pingping Ren, Lan Lan, Xiaoqi Shen, Liangliang Chen, Ying Xu, Jun Cheng, Xiayu Li, Jianghua Chen, Fei Han   +13 more
doaj   +1 more source

Efficacy of CD19-guided B-cell depletion with rituximab plus steroids in refractory focal segmental glomerulosclerosis

BMC Nephrology
Objective Refractory focal segmental glomerulosclerosis (FSGS) poses significant therapeutic challenges under conventional immunosuppressants. Although rituximab (RTX), an anti-CD20 monoclonal antibody, has demonstrated efficacy in nephrotic syndrome ...
Liangliang Chen, Xiaoli Lin, Xiaohan Huang, Yanhong Ma, Fanghao Cai, Huanhuan Zhu, Lan Lan, Pingping Ren, Jianghua Chen, Junni Wang, Fei Han   +10 more
doaj   +1 more source

Remnant cholesterol, high-sensitivity C-reactive protein, and risk of incident coronary heart disease among patients with chronic kidney disease based on UK biobank

Nutrition & Metabolism
Background Patients with chronic kidney disease (CKD) exhibit elevated remnant cholesterol (RC) and high-sensitivity C-reactive protein (hs-CRP), and both of them contribute to the residual cardiovascular risk.
Minghui Han, Jing Zhou, Zhenzhen Wan, Meng Chen, Mengli Yan, Wei Feng, Ge Wang, Jing Zhang, Lina Zhang, Lei Yan, Fengmin Shao, Yue Gu   +11 more
doaj   +1 more source

Comparison and prognostic analysis of focal segmental glomerulosclerosis patients with or without nephrotic syndrome at onset

BMC Nephrology
Background Focal segmental glomerulosclerosis (FSGS) constituted one of the most common causes of end-stage kidney disease. We aimed to compare the presentation and prognosis for FSGS patients based on whether they met the criteria of nephrotic syndrome (
Liangliang Chen, Yanhong Ma, Xiaohan Huang, Junni Wang, Xiaoli Lin, Fanghao Cai, Huijing Wang, Huanhuan Zhu, Lan Lan, Pingping Ren, Jianghua Chen, Fei Han   +11 more
doaj   +1 more source

Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis

BMC Nephrology
Background Up to now, there is no unequivocal intervention to mitigate vascular calcification (VC) in patients with hemodialysis. This network meta-analysis aimed to systematically evaluate the clinical efficacy of sodium thiosulfate, bisphosphonates ...
Lei He, Yuzhe Li, Jingjing Jin, Meijuan Cheng, Yaling Bai, Jinsheng Xu   +5 more
doaj   +1 more source